Combination of melanoma drugs Ipilimumab and Nivolumab shrink tumour cells in 60%

Melanoma Cancer Cell

There are several new drugs now being used to treat malignant melanoma. Melanoma, the most serious form of skin cancer, is the sixth most common cancer in the UK – it kills more than 2,000 people in Britain each year.

An international study on 945 people showed that taking both drugs led to tumours shrinking by at least a third in 58% of patients – with the tumours stable or shrinking for an average of 11.5 months.

In this randomized, double-blind, phase 3 study, nivolumab alone or nivolumab plus ipilimumab was compared with ipilimumab alone in patients with metastatic melanoma.

This data was published in the New England Journal of Medicine. Click here for link


Lorem ipsum dolor sit amet consectetur adipiscing elit dolor

Leave a Reply

Your email address will not be published. Required fields are marked *

New Clinic in North Wales

Dr Clayton is delighted to announce that he has joined a team of colleagues in North Wales to help deliver private dermatology clinics in the

New TV Show

Last year I took part in a BBC1 series looking at skin problems affecting young people. The program was filmed over several weeks at a